Alzheimer’s Disease Diagnostic Global Market Report 2025

Global Alzheimer’s Disease Diagnostic Market Report 2025

Alzheimer’s Disease Diagnostic Global Market Report 2025 - By Type (Triage, Diagnosis, Screening), By Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), By End User (Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center) - Market Size, Trends, And Global Forecast 2025-2034

Name: Alzheimer’s Disease Diagnostic Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Alzheimer’s Disease Diagnostic Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Alzheimer’s Disease Diagnostic Global Market Report 2025

Proud Members Of

What Is Covered Under Alzheimer’s Disease Diagnostic Market?

Alzheimer’s disease diagnostics encompass methods and tools used to detect and confirm the presence of Alzheimer’s disease, a progressive neurodegenerative disorder. These diagnostics include cognitive assessments, imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans, and biomarker tests analyzing cerebrospinal fluid (CSF) or blood for amyloid-beta and tau proteins.

The main types of alzheimer’s disease diagnostics are triage, diagnosis, and screening. Triage is a systematic approach for prioritizing patients depending on the urgency and severity of their cognitive symptoms. The diagnostic techniques include biomarkers, imaging techniques, genetic testing, and cognitive assessment tests, and they are used by various end users such as clinics, hospitals, diagnostic centers, pharmaceutical companies, and academic research centers.

What Is The Alzheimer’s Disease Diagnostic Market Size 2025 And Growth Rate?

The alzheimer's disease diagnostic market size has grown rapidly in recent years. It will grow from $6.56 billion in 2024 to $7.28 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to rising prevalence of Alzheimer’s disease and dementia, growing awareness of the importance of early diagnosis for better management, advancements in imaging technologies, such as MRI and PET scans, increasing investment in research and development for neurodegenerative diseases, government initiatives and funding for Alzheimer’s research and diagnostics.

What Is The Alzheimer’s Disease Diagnostic Market Growth Forecast?

The alzheimer's disease diagnostic market size is expected to see rapid growth in the next few years. It will grow to $10.91 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to development of blood-based biomarkers for non-invasive diagnosis, rising demand for personalized medicine and precision diagnostics, integration of AI and machine learning in diagnostic tools for early detection, growing adoption of digital health technologies for remote monitoring and diagnosis, expansion of healthcare infrastructure in emerging markets to improve accessibility. Major trends in the forecast period include emergence of multi-modal diagnostic approaches combining imaging, biomarkers, and cognitive tests, increasing focus on point-of-care diagnostic solutions for faster results, development of wearable devices for continuous monitoring of cognitive health, rising collaborations between biotech companies and research institutions for innovative solutions, growth in direct-to-consumer genetic testing for Alzheimer’s risk assessment.

Alzheimer’s Disease Diagnostic Market Size and growth rate 2025 to 2029: Graph

How Is The Alzheimer’s Disease Diagnostic Market Segmented?

The alzheimer’s disease diagnostic market covered in this report is segmented –

1) By Type: Triage, Diagnosis, Screening

2) By Diagnostic Technique: Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests

3) By End User: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center

Subsegments:

1) By Triage: Cognitive Testing, Imaging Techniques

2) By Diagnosis: Biomarker Testing, Neuroimaging

3) By Screening: Neuropsychological Testing, Genetic Testing

Book your 30 minutes free consultation with our research experts

What Is Driving The Alzheimer’s Disease Diagnostic Market? Impact Of Chronic Disease Growth On Alzheimer’s Disease Diagnostic Industry

The increase in chronic disease is expected to propel the growth of the alzheimer’s disease diagnostic market going forward. Chronic disease is a chronic condition or chronic sickness, a health condition that persists or lasts for over three months. The increase in chronic disease is driven by the increased frequency of several interconnected factors, including lifestyle choices, environmental influences, genetic predisposition, and socioeconomic conditions. The presence of chronic conditions such as cardiovascular difficulties, diabetes, and hypertension increases the chance of acquiring Alzheimer's disease (AD) and other kinds of dementia. For instance, in January 2022, according to a report shared by the American Heart Association Inc., a US-based nonprofit voluntary organization, brain disorders are expected to increase to 9.3 million in the US by 2060, and currently, this number is growing in the US. and one in every six people worldwide suffers from a brain disease. Currently, 1 billion people will suffer from brain disorders worldwide by 2021. Therefore, the increase in chronic disease will drive the growth of the alzheimer’s disease diagnostic market.

Who Are The Major Players In The Global Alzheimer’s Disease Diagnostic Market?

Major companies operating in the alzheimer’s disease diagnostic market are Pfizer Inc., AbbVie, Bristol Myers Squibb Company, Hoffmann-La Roche, Eli Lilly and Company, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Daiichi Sankyo Co., Sysmex, Lantheus, Quanterix, FujireBio, TauRx Pharmaceuticals Ltd, AC Immune, C2N diagnostics, AXON Neuroscience, Neuro-Bio Ltd, Anavex Life Sciences Corp., Treventis Corporation

What Are The Key Trends Of The Global Alzheimer’s Disease Diagnostic Market? Advancements In Technology In Alzheimer’s Diagnostic With Accurate Test Results

Major companies operating in the alzheimer’s disease diagnostic market are focusing on advancements of blood-based biomarker test which is expected to simplify the diagnostic process for Alzheimer's disease, reducing reliance on more invasive procedures and improving access to timely treatment for patients. For instance, in October 2023, Quanterix, a US-based biotechnology research company, launched LucentAD p-Tau 217 test, a biomarker for Alzheimer's pathology with clinical sensitivity and specificity in blood. Traditional approaches for cerebrospinal fluid (CSF) biomarkers include positron emission tomography (PET) or lumbar puncture, both of which are costly, invasive, and not widely available. Additionally, it combines Quanterix's ultra-sensitive SimoaÒ technology with J&J Innovative Medicine's well tested p-Tau 217 antibodies for excellent accuracy and a simpler process.

What Are Latest Mergers And Acquisitions In The Alzheimer’s Disease Diagnostic Market? Lantheus Acquired Meilleur Technologies To Strengthen Product Portfolio

In July 2024, Lantheus, a US-based radiopharmaceutical company, acquired Meilleur Technologies for an undisclosed amount. Through this acquisition, Lantherus aims in expanding its holdings of PET imaging agents for Alzheimer’s disease. Meilleur Technologies is a US biopharma company that has collaborated with research institutions to develop imaging biomarkers for Alzheimer's disease.

What Is The Regional Outlook For The Global Alzheimer’s Disease Diagnostic Market?

North America was the largest region in the alzheimer's disease diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alzheimer’s disease diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alzheimer’s disease diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Alzheimer’s Disease Diagnostic Market?

The alzheimer's disease diagnostic market consists of revenues earned by entities by providing services such as cognitive assessment tests, genetic tests, biomarker tests, and cerebrospinal fluid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The alzheimer's disease diagnostic market also includes sales of genetic testing kits, cognitive assessment tools, imaging equipment, biomarker kits, and wearable devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Alzheimer’s Disease Diagnostic Industry?

The alzheimer’s disease diagnostic market research report is one of a series of new reports from The Business Research Company that provides alzheimer’s disease diagnostic market statistics, including alzheimer’s disease diagnostic industry global market size, regional shares, competitors with a alzheimer’s disease diagnostic market share, detailed alzheimer’s disease diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the alzheimer’s disease diagnostic industry. This alzheimer’s disease diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Alzheimers Disease Diagnostic Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$7.28 billion
Revenue Forecast In 2034	$10.91 billion
Growth Rate	CAGR of 10.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The alzheimer’s disease diagnostic market covered in this report is segmented – 1) By Type: Triage, Diagnosis, Screening 2) By Diagnostic Technique: Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests 3) By End User: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center Subsegments: 1) By Triage: Cognitive Testing, Imaging Techniques 2) By Diagnosis: Biomarker Testing, Neuroimaging 3) By Screening: Neuropsychological Testing, Genetic Testing
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., AbbVie, Bristol Myers Squibb Company, Hoffmann-La Roche, Eli Lilly and Company, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Daiichi Sankyo Co., Sysmex, Lantheus, Quanterix, FujireBio, TauRx Pharmaceuticals Ltd, AC Immune, C2N diagnostics, AXON Neuroscience, Neuro-Bio Ltd, Anavex Life Sciences Corp., Treventis Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Alzheimer’s Disease Diagnostic Market Characteristics

3. Alzheimer’s Disease Diagnostic Market Trends And Strategies

4. Alzheimer’s Disease Diagnostic Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Alzheimer’s Disease Diagnostic Growth Analysis And Strategic Analysis Framework

5.1. Global Alzheimer’s Disease Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Alzheimer’s Disease Diagnostic Market Growth Rate Analysis

5.4. Global Alzheimer’s Disease Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Alzheimer’s Disease Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Alzheimer’s Disease Diagnostic Total Addressable Market (TAM)

6. Alzheimer’s Disease Diagnostic Market Segmentation

6.1. Global Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Triage

Diagnosis

Screening

6.2. Global Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biomarkers

Imaging Techniques

Genetic Testing

Cognitive Assessment Tests

6.3. Global Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinics

Hospitals

Diagnostic Centers

Pharmaceutical Companies

Academic Research Center

6.4. Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Triage, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cognitive Testing

Imaging Techniques

6.5. Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biomarker Testing

Neuroimaging

6.6. Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neuropsychological Testing

Genetic Testing

7. Alzheimer’s Disease Diagnostic Market Regional And Country Analysis

7.1. Global Alzheimer’s Disease Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Alzheimer’s Disease Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Alzheimer’s Disease Diagnostic Market

8.1. Asia-Pacific Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Alzheimer’s Disease Diagnostic Market

9.1. China Alzheimer’s Disease Diagnostic Market Overview

9.2. China Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Alzheimer’s Disease Diagnostic Market

10.1. India Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Alzheimer’s Disease Diagnostic Market

11.1. Japan Alzheimer’s Disease Diagnostic Market Overview

11.2. Japan Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Alzheimer’s Disease Diagnostic Market

12.1. Australia Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Alzheimer’s Disease Diagnostic Market

13.1. Indonesia Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Alzheimer’s Disease Diagnostic Market

14.1. South Korea Alzheimer’s Disease Diagnostic Market Overview

14.2. South Korea Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Alzheimer’s Disease Diagnostic Market

15.1. Western Europe Alzheimer’s Disease Diagnostic Market Overview

15.2. Western Europe Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Alzheimer’s Disease Diagnostic Market

16.1. UK Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Alzheimer’s Disease Diagnostic Market

17.1. Germany Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Alzheimer’s Disease Diagnostic Market

18.1. France Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Alzheimer’s Disease Diagnostic Market

19.1. Italy Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Alzheimer’s Disease Diagnostic Market

20.1. Spain Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Alzheimer’s Disease Diagnostic Market

21.1. Eastern Europe Alzheimer’s Disease Diagnostic Market Overview

21.2. Eastern Europe Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Alzheimer’s Disease Diagnostic Market

22.1. Russia Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Alzheimer’s Disease Diagnostic Market

23.1. North America Alzheimer’s Disease Diagnostic Market Overview

23.2. North America Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Alzheimer’s Disease Diagnostic Market

24.1. USA Alzheimer’s Disease Diagnostic Market Overview

24.2. USA Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Alzheimer’s Disease Diagnostic Market

25.1. Canada Alzheimer’s Disease Diagnostic Market Overview

25.2. Canada Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Alzheimer’s Disease Diagnostic Market

26.1. South America Alzheimer’s Disease Diagnostic Market Overview

26.2. South America Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Alzheimer’s Disease Diagnostic Market

27.1. Brazil Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Alzheimer’s Disease Diagnostic Market

28.1. Middle East Alzheimer’s Disease Diagnostic Market Overview

28.2. Middle East Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Alzheimer’s Disease Diagnostic Market

29.1. Africa Alzheimer’s Disease Diagnostic Market Overview

29.2. Africa Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Alzheimer’s Disease Diagnostic Market Competitive Landscape And Company Profiles

30.1. Alzheimer’s Disease Diagnostic Market Competitive Landscape

30.2. Alzheimer’s Disease Diagnostic Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Alzheimer’s Disease Diagnostic Market Other Major And Innovative Companies

31.1. Siemens Healthineers AG

31.2. Laboratory Corporation of America Holdings

31.3. Quest Diagnostics Incorporated

31.4. Daiichi Sankyo Co.

31.5. Sysmex

31.6. Lantheus

31.7. Quanterix

31.8. FujireBio

31.9. TauRx Pharmaceuticals Ltd

31.10. AC Immune

31.11. C2N diagnostics

31.12. AXON Neuroscience

31.13. Neuro-Bio Ltd

31.14. Anavex Life Sciences Corp.

31.15. Treventis Corporation

32. Global Alzheimer’s Disease Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alzheimer’s Disease Diagnostic Market

34. Recent Developments In The Alzheimer’s Disease Diagnostic Market

35. Alzheimer’s Disease Diagnostic Market High Potential Countries, Segments and Strategies

35.1 Alzheimer’s Disease Diagnostic Market In 2029 - Countries Offering Most New Opportunities

35.2 Alzheimer’s Disease Diagnostic Market In 2029 - Segments Offering Most New Opportunities

35.3 Alzheimer’s Disease Diagnostic Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Triage, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Alzheimer’s Disease Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Alzheimer’s Disease Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: AbbVie Financial Performance

Table 79: Bristol Myers Squibb Company Financial Performance

Table 80: Hoffmann-La Roche Financial Performance

Table 81: Eli Lilly and Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Triage, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Alzheimer’s Disease Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Alzheimer’s Disease Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: AbbVie Financial Performance

Figure 79: Bristol Myers Squibb Company Financial Performance

Figure 80: Hoffmann-La Roche Financial Performance

Figure 81: Eli Lilly and Company Financial Performance

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

What Is The Biohacking Market Overview In 2022?

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services), By Application (Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Other Applications), By End-User (Hospitals, Laboratories, and Other End-Users (Blood Banks, Home Health Agencies, and Nursing Homes) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Diagnostic Imaging Equipment Global Market Report 2025 – By Type (X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2025-2034

View Report

3D Diagnostic Imaging Services Global Market Report 2025 – By Technique (Ultrasound, MRI, X-ray, Computed Tomography, Other Techniques), By Application (Oncology, Cardiology, Orthopedic, Other Applications), By End User (Diagnostic Centers, Hospitals, Research Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hematology Diagnostic Devices And Equipment Global Market Report 2025 – By Product (Instruments, Consumables), By Instruments (Analyzers, Flow cytometers, Other Instruments), By Consumables (Reagents, Stains, Other Consumables), By Application (Drug Testing, Auto-Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, Other Applications), By End User (Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immunochemistry Diagnostic Devices And Equipment Global Market Report 2025 – By Product Type (Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables), By Consumables (Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables), By Application (Endocrinology, Oncology, Cardiology, Therapeutic Drug Development & Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications), By End Users (Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Molecular Diagnostics Devices And Equipment Global Market Report 2025 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2025 – By Product (Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits), By Device Technology (Automated, Semi-Automated, Manual), By End User (Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Alzheimer's Disease Diagnostic market?

How will the Alzheimer's Disease Diagnostic market drivers and restraints affect the market dynamics? What forces will shape the Alzheimer's Disease Diagnostic industry going forward?

The Alzheimer's Disease Diagnostic market major growth driver - Impact Of Chronic Disease Growth On Alzheimer’s Disease Diagnostic Industry. For further insights on the Alzheimer's Disease Diagnostic market, request a sample here

What is the forecast market size or the forecast market value of the Alzheimer's Disease Diagnostic market?

The Alzheimer's Disease Diagnostic market size has grown strongly in recent years. The alzheimer's disease diagnostic market size has grown rapidly in recent years. It will grow from $6.56 billion in 2024 to $7.28 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to rising prevalence of Alzheimer’s disease and dementia, growing awareness of the importance of early diagnosis for better management, advancements in imaging technologies, such as MRI and PET scans, increasing investment in research and development for neurodegenerative diseases, government initiatives and funding for Alzheimer’s research and diagnostics. The alzheimer's disease diagnostic market size is expected to see rapid growth in the next few years. It will grow to $10.91 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to development of blood-based biomarkers for non-invasive diagnosis, rising demand for personalized medicine and precision diagnostics, integration of AI and machine learning in diagnostic tools for early detection, growing adoption of digital health technologies for remote monitoring and diagnosis, expansion of healthcare infrastructure in emerging markets to improve accessibility. Major trends in the forecast period include emergence of multi-modal diagnostic approaches combining imaging, biomarkers, and cognitive tests, increasing focus on point-of-care diagnostic solutions for faster results, development of wearable devices for continuous monitoring of cognitive health, rising collaborations between biotech companies and research institutions for innovative solutions, growth in direct-to-consumer genetic testing for Alzheimer’s risk assessment. For further insights on the Alzheimer's Disease Diagnostic market, request a sample here

How is the Alzheimer's Disease Diagnostic market segmented?

The alzheimer’s disease diagnostic market covered in this report is segmented –
1) By Type: Triage, Diagnosis, Screening
2) By Diagnostic Technique: Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests
3) By End User: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center

Subsegments:
1) By Triage: Cognitive Testing, Imaging Techniques
2) By Diagnosis: Biomarker Testing, Neuroimaging
3) By Screening: Neuropsychological Testing, Genetic Testing For further insights on the Alzheimer's Disease Diagnostic market, request a sample here

Which region has the largest share of the Alzheimer's Disease Diagnostic market? What are the other regions covered in the report?

Who are the major players in the Alzheimer's Disease Diagnostic market?

What are the key trends in the Alzheimer's Disease Diagnostic market?

Major trends in the Alzheimer's Disease Diagnostic market include Advancements In Technology In Alzheimer’s Diagnostic With Accurate Test Results. For further insights on the Alzheimer's Disease Diagnostic market, request a sample here.

What are the major opportunities in the Alzheimer's Disease Diagnostic market? What are the strategies for the Alzheimer's Disease Diagnostic market?

For detailed insights on the major opportunities and strategies in the Alzheimer's Disease Diagnostic market, request a sample here.

How does the Alzheimer's Disease Diagnostic market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Alzheimer's Disease Diagnostic market growth and SWOT analysis of the Alzheimer's Disease Diagnostic industry, request a sample here.

For detailed insights on Alzheimer's Disease Diagnostic's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Alzheimer's Disease Diagnostic industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Alzheimer's Disease Diagnostic industry,

What are the key dynamics influencing the Alzheimer's Disease Diagnostic market growth? SWOT analysis of the Alzheimer's Disease Diagnostic market. request a sample here.